Product NDC: | 57619-300 |
Proprietary Name: | Nazil |
Non Proprietary Name: | Naphazoline Hydrochloride |
Active Ingredient(s): | .2 mg/mL & nbsp; Naphazoline Hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57619-300 |
Labeler Name: | LABORATORIOS SOPHIA, S.A. DE C.V. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part349 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20100412 |
Package NDC: | 57619-300-01 |
Package Description: | 1 BOTTLE, PLASTIC in 1 PACKAGE (57619-300-01) > 15 mL in 1 BOTTLE, PLASTIC |
NDC Code | 57619-300-01 |
Proprietary Name | Nazil |
Package Description | 1 BOTTLE, PLASTIC in 1 PACKAGE (57619-300-01) > 15 mL in 1 BOTTLE, PLASTIC |
Product NDC | 57619-300 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Naphazoline Hydrochloride |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 20100412 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | LABORATORIOS SOPHIA, S.A. DE C.V. |
Substance Name | NAPHAZOLINE HYDROCHLORIDE |
Strength Number | .2 |
Strength Unit | mg/mL |
Pharmaceutical Classes |